Monitoring and Evaluation (M&E)
is an integral part of any program to assess its impact, identify strong and weak sides and to provide information for making future management decisions, strengthen intervention and defining of optimal financing of program activities.
In health care, while working with complex epidemiological processes, including TB epidemic, while planning the program activities of fighting the epidemic, particular attention should be paid to the defining of its efficiency. Hence monitoring and evaluation should be the main tool for data collection, analysis and use of adequate, accurate and accessible information from different sources in order to make informed management decisions.
Surveillance
is a permanent collection of epidemiological data (treatment outcomes) to track dynamic changes on the incidence or prevalence during the long period of time. Surveillance data are collected from local to national level. It is an important source of information for M&E, but not always is identical to M&E indicators. Surveillance data shows the epidemic trends of treatment outcomes, but sometimes may not indicate the impact of a program. Data obtained in surveillance should be analyzed along with other sources of program data in the monitoring system.
This section of website contains the analytical review of TB in the world, in Europe and in Ukraine (general and by regions). The analysis is based on surveillance data and national statistics and reflects the underlying epidemiological processes in terms of key indicators proposed by WHO to analyze the effectiveness of anti-TB activities.